Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery
ChemMedChem · 25.02.2026 · 21 (4)
DOI: 10.1002/cmdc.202501080 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 20.02.2026. Verfasst von Ariane F Hübner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical and Biomedical Sciences (IPBS), Johannes Gutenberg-University, Mainz, Germany. Hauptthemen laut MEDLINE: Drug Discovery, Small Molecule Libraries. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Direct‐to‐biology (D2B) has emerged as a transformative concept in early drug discovery, defined by the direct on‐target screening of crude reaction mixtures without prior purification. First coined in 2021, the approach builds on advances in nanoscale synthesis platforms and was shaped by seminal studies that demonstrated the feasibility of plate‐based microscale chemistry for library generation. Today, D2B is increasingly adopted in academia and industry, with campaigns exploring diverse reaction classes, targeting modalities, and assay platforms. Thus, very recently, the first commercial providers now offer D2B services for ligand optimization, further driving adoption. Yet, despite clear advantages in speed, cost, and sustainability, D2B also faces limitations from assay interference and technical constraints in reaction miniaturization. Looking ahead, integration with AI‐driven design and high‐content biology promises to expand the scope of D2B and position it as a robust complement to traditional discovery paradigms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical and Biomedical Sciences (IPBS), Johannes Gutenberg-University, Mainz, Germany.
ORCID-Profile: Fabian Barthels
Zitieren
APA
Hübner, A. F., & Barthels, F. (2026). Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery. ChemMedChem, 21(4). https://doi.org/10.1002/cmdc.202501080
Vancouver
Hübner AF, Barthels F. Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery. ChemMedChem. 2026;21(4). doi:10.1002/cmdc.202501080
BibTeX
@article{Hbner2026,
author = {Hübner, Ariane F and Barthels, Fabian},
title = {Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {4},
doi = {10.1002/cmdc.202501080}
}
EUVIMED